Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 847170-51-8 | MDL No. : | MFCD08275686 |
Formula : | C15H13ClN2O4S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LEQSFEFOQFAWKA-UHFFFAOYSA-N |
M.W : | 352.79 | Pubchem ID : | 7938498 |
Synonyms : |
|
Num. heavy atoms : | 23 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.2 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 92.88 |
TPSA : | 91.58 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.98 cm/s |
Log Po/w (iLOGP) : | 2.17 |
Log Po/w (XLOGP3) : | 3.48 |
Log Po/w (WLOGP) : | 4.09 |
Log Po/w (MLOGP) : | 2.09 |
Log Po/w (SILICOS-IT) : | 0.61 |
Consensus Log Po/w : | 2.49 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.41 |
Solubility : | 0.0138 mg/ml ; 0.0000391 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -5.09 |
Solubility : | 0.0029 mg/ml ; 0.00000821 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -4.96 |
Solubility : | 0.00386 mg/ml ; 0.0000109 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.76 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1145678-74-5 ]
(1-Tosyl-1H-indol-4-yl)methanamine
Similarity: 0.71
[ 374783-78-5 ]
(S)-2-Methyl-1-((4-nitrophenyl)sulfonyl)aziridine
Similarity: 0.69
[ 80360-20-9 ]
1-(Phenylsulfonyl)-1H-indole-3-carbaldehyde
Similarity: 0.69
[ 24310-36-9 ]
1-(Toluene-4-sulfonyl)-1,2,3,4-tetrahydrobenzo[b]azepin-5-one
Similarity: 0.68
[ 165668-41-7 ]
N-(3-Chloro-1H-indol-7-yl)benzene-1,4-disulfonamide
Similarity: 0.68
[ 26638-53-9 ]
3-Chloro-6,11-dihydro-6-methyl-5,5,11-trioxodibenzo[c,f][1,2]thiazepine
Similarity: 0.71
[ 165668-41-7 ]
N-(3-Chloro-1H-indol-7-yl)benzene-1,4-disulfonamide
Similarity: 0.68
[ 882562-40-5 ]
3-(2,5-Dichloropyrimidin-4-yl)-1-(phenylsulfonyl)-1H-indole
Similarity: 0.68
[ 1429309-33-0 ]
1-((4-Bromophenyl)sulfonyl)-4-chloro-5-nitro-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.66
[ 96-72-0 ]
2-Chloro-5-nitrobenzenesulfonamide
Similarity: 0.63
[ 26638-53-9 ]
3-Chloro-6,11-dihydro-6-methyl-5,5,11-trioxodibenzo[c,f][1,2]thiazepine
Similarity: 0.71
[ 1145678-74-5 ]
(1-Tosyl-1H-indol-4-yl)methanamine
Similarity: 0.71
[ 374783-78-5 ]
(S)-2-Methyl-1-((4-nitrophenyl)sulfonyl)aziridine
Similarity: 0.69
[ 80360-20-9 ]
1-(Phenylsulfonyl)-1H-indole-3-carbaldehyde
Similarity: 0.69
[ 24310-36-9 ]
1-(Toluene-4-sulfonyl)-1,2,3,4-tetrahydrobenzo[b]azepin-5-one
Similarity: 0.68
[ 374783-78-5 ]
(S)-2-Methyl-1-((4-nitrophenyl)sulfonyl)aziridine
Similarity: 0.69
[ 1429309-33-0 ]
1-((4-Bromophenyl)sulfonyl)-4-chloro-5-nitro-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.66
[ 22952-24-5 ]
6-Nitrobenzo[d]isothiazol-3(2H)-one 1,1-dioxide
Similarity: 0.65
[ 96-72-0 ]
2-Chloro-5-nitrobenzenesulfonamide
Similarity: 0.63
[ 49690-09-7 ]
N-tert-Butyl 4-Nitrophenylsulfonamide
Similarity: 0.63